Aap Implantate AG Stock
Price
Target price
€1.40
€1.40
2.210%
0.03
2.210%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Aap Implantate AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Aap Implantate
sharewise wants to provide you with the best news and tools for Aap Implantate, so we directly link to the best financial data sources.
Financials
News
EQS-Adhoc: aap Implantate AG: Cash capital increase
EQS-Adhoc: aap Implantate AG: Cash capital increase
EQS-News: aap Implantate AG reports strong growth in Q3/2025: +15%
EQS-News: aap Implantate AG reports strong growth in Q3/2025: +15%
EQS-News: aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
EQS-News: aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
EQS-News: aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion
EQS-News: aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion
EQS-News: aap successfully completes human clinical trial for antibacterial surface technology
EQS-News: aap successfully completes human clinical trial for antibacterial surface technology
EQS-News: aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
EQS-News: aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
EQS-News: aap Implantate AG publishes final audited consolidated financial statements 2024 - confirmation of strong operational improvement
EQS-News: aap Implantate AG publishes final audited consolidated financial statements 2024 - confirmation of strong operational improvement
EQS-News: aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment
EQS-News: aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment
EQS-Adhoc: aap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements
EQS-Adhoc: aap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements